The kinetic stability of MHC class II: Peptide complexes is a key parameter that dictates immunodominance

被引:180
|
作者
Lazarski, CA
Chaves, FA
Jenks, SA
Wu, SH
Richards, KA
Weaver, JM
Sant, AJ
机构
[1] Univ Rochester, David H Smith Ctr Vaccine Biol & Immunol, Aab Inst Biomed Sci, Dept Microbiol & Immunol, Rochester, NY 14642 USA
[2] Univ Chicago, Div Biol Sci, Comm Immunol, Chicago, IL 60637 USA
关键词
D O I
10.1016/j.immuni.2005.05.009
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
T cell priming to exogenous antigens reflects regulated antigen processing in dendritic cells, subsequent homing to lymph nodes, sustained interactions between T cells and antigen-bearing dendritic cells, and, ultimately, selective T cell activation and differentiation. In this study, we test the hypothesis that an intrinsic property of the class II:peptide complex is a key determinant that dictates the specificity of an emerging CD4 T cell response. We found that immunodominant peptides possess extremely long half-lives with class II molecules (t(1/2) > 150 hr), whereas cryptic peptides displayed half-lives of less than 10 hr. Furthermore, and most importantly, by using a peptide shuttle vector and four independent antigens, we demonstrate a direct, causative relationship between the half-life of peptide epitopes and their immunogenicity in vivo. Taken collectively, our results suggest the half-life of class II:peptide complexes is the primary parameter that dictates the ultimate hierarchy of the elicited T cell response.
引用
收藏
页码:29 / 40
页数:12
相关论文
共 50 条
  • [1] The relationship between immunodominance, DM editing, and the kinetic stability of MHC class II:peptide complexes
    Sant, AJ
    Chaves, FA
    Jenks, SA
    Richards, KA
    Menges, P
    Weaver, JM
    Lazarski, CA
    IMMUNOLOGICAL REVIEWS, 2005, 207 : 261 - 278
  • [2] Tapasin shapes immunodominance hierarchies according to the kinetic stability of peptide - MHC class I complexes
    Thirdborough, Stephen M.
    Roddick, Joanne S.
    Radcliffe, Joanna N.
    Howarth, Mark
    Stevenson, Freda K.
    Elliott, Tim
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2008, 38 (02) : 364 - 369
  • [3] Immunodominance does not result from peptide competition for MHC class II presentation
    Lo-Man, R
    Langeveld, JPM
    Martineau, P
    Hofnung, M
    Meloen, RH
    Leclerc, C
    JOURNAL OF IMMUNOLOGY, 1998, 160 (04): : 1759 - 1766
  • [4] MHC class I peptide stability: Implications for immunodominance, in vitro proliferation, and diversity of responding CTL
    Busch, DH
    Pamer, EG
    JOURNAL OF IMMUNOLOGY, 1998, 160 (09): : 4441 - 4448
  • [5] Kinetic isomers of a class II MHC-peptide complex
    Schmitt, L
    Boniface, JJ
    Davis, MM
    McConnell, HM
    BIOCHEMISTRY, 1998, 37 (50) : 17371 - 17380
  • [6] Cooperativity during the formation of peptide/MHC class II complexes
    Anderson, MW
    Gorski, J
    BIOCHEMISTRY, 2005, 44 (15) : 5617 - 5624
  • [7] TCR recognition of peptide/MHC class II complexes and superantigens
    Sundberg, Eric J.
    Deng, Lu
    Mariuzza, Roy A.
    SEMINARS IN IMMUNOLOGY, 2007, 19 (04) : 262 - 271
  • [8] High peptide affinity for MHC class I does not correlate with immunodominance
    Müllbacher, A
    Lobigs, M
    Yewdell, JW
    Bennink, JR
    Hla, RT
    Blanden, RV
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1999, 50 (04) : 420 - 426
  • [9] Catalysis of peptide dissociation from class II MHC-peptide complexes
    Schmitt, L
    Kratz, JR
    Davis, MM
    McConnell, HM
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (12) : 6581 - 6586
  • [10] Ii-Key/MHC class II epitope hybrid peptide vaccines for HIV
    Kallinteris, NL
    Lu, XQ
    Wu, SZ
    Hu, HL
    Li, Y
    Gulfo, JV
    Humphreys, RE
    Xu, MZ
    VACCINE, 2003, 21 (27-30) : 4128 - 4132